B2M and neoplasm: Taken together with the high HEV counts in Lynch syndrome CRCs, our findings point towards a longer process of immunoediting in Lynch syndrome CRCs, possibly due to pre-existing MMR-deficient crypts, explaining the higher proportion of B2M mutations in the tumours from Lynch syndrome patients compared with the sporadic ones.8